Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study.
Manuel Sánchez CánovasPaula Jimenez-FonsecaDavid Fernández GarayMónica Cejuela SolísDiego Casado ElíaEva Coma SalvansIrma de la Haba VacasDavid GomezAna Fernández MontésRoberto Morales GiménezMercedes Biosca Gómez de TejadaVirginia Arrazubi ArrulaSilvia Sequero LópezRemedios Otero CandeleraCristina Sánchez CendraMarina Justo de la PeñaDiana Moreno MuñozMayra Orillo SarmientoEva Martínez de CastroIgnacio García EscobarAlejandro Bernal VidalLaura Ortega MoranAndrés J Muñoz MartínRodrigo Sánchez BayonaMaría José Martínez OrtizFrancisco Ayala de la PeñaVicente VicenteAlberto Carmona-BayonasPublished in: PloS one (2023)
We have validated the EPIPHANY Index in patients with incidental or symptomatic cancer-related PE. This model can contribute to standardize decision-making in a scenario lacking quality evidence.